Thus, with pdx1 mutant zebrafish, pharmacologic effects and toxicities of new diabetes drug candidates can be evaluated at relatively low cost in a vertebrate whole-animal model before moving on to costly and labor-intensive mammalian studies. The gene discussed is PDX1; the disease is diabetes mellitus.